Taiwan Advanced Nanotech Inc.
TWO: 6797.TWO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taipei Exchange
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Chien Hsing Chien
- Employees
- 292
- Headquarters
- Taoyuan, Taiwan
- IPO year
- 2020
- Market cap
- NT$428.4M
- Website
- https://www.tanbead.com
Loading 6797…
Loading profile data…Frequently asked questions about 6797
What does Taiwan Advanced Nanotech Inc. (6797.TWO) do?
Taiwan Advanced Nanotech Inc. designs and manufactures products for nucleic acid purification. The company's products include reagent kits, which are used in DNA/RNA extractions from samples of blood, cell, tissue, plant, bacteria, virus, etc.; magnetic nanoparticles, including super-paramagnetic iron oxide and ultra small super-paramagnetic iro...
Where does 6797.TWO trade?
Taiwan Advanced Nanotech Inc. (6797.TWO) trades on the Taipei Exchange.
What sector is 6797.TWO in?
Taiwan Advanced Nanotech Inc. (6797.TWO) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of Taiwan Advanced Nanotech Inc.?
Chien Hsing Chien is the chief executive officer of Taiwan Advanced Nanotech Inc. (6797.TWO).
Where is Taiwan Advanced Nanotech Inc. headquartered?
Taiwan Advanced Nanotech Inc. is headquartered in Taiwan.
Does 6797.TWO pay a dividend?
Taiwan Advanced Nanotech Inc. (6797.TWO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 6797.TWO go public?
Taiwan Advanced Nanotech Inc. (6797.TWO) completed its initial public offering in 2020.